113 related articles for article (PubMed ID: 911535)
1. [Comparative study of the effects of various antiarrhythmic drugs on the frequency of ventricular response during established atrial fibrillation].
Bracchetti D; Frabetti L; Mambelli M; Stefanini A; Magnani B
Boll Soc Ital Cardiol; 1977; 22(1):51-5. PubMed ID: 911535
[No Abstract] [Full Text] [Related]
2. Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents.
Cargnelli G; Domeneghetti F; Ferrari M; Malacini P; Roberti G
Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):384-8. PubMed ID: 892956
[TBL] [Abstract][Full Text] [Related]
3. [Influence of cardiac agents on the diastolic irritability of the ventricular myocardium. Consequences for pacemaker therapy].
Doenecke P
Ann Univ Sarav Med; 1976; 23(2):81-122. PubMed ID: 938002
[No Abstract] [Full Text] [Related]
4. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
Femmer K; Grünheid K
Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
[No Abstract] [Full Text] [Related]
6. Inotropic and chronotropic effects of antiarrhythmic agents onisolated blood-perfused canine ventricular tissue.
Hashimoto K; Tsukada T; Matsuda H
Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():451-5. PubMed ID: 1031944
[TBL] [Abstract][Full Text] [Related]
7. [Anti-arrhythmia agents].
Kaufmann G
Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
[No Abstract] [Full Text] [Related]
8. [Myocardial excitability under the influence of digitalis glycosides and anti-arrhythmia agent].
Doenecke VP
Fortschr Med; 1977 Jan; 95(3):163-6. PubMed ID: 838426
[TBL] [Abstract][Full Text] [Related]
9. Is there a role for digoxin in atrial fibrillation without heart failure?
Master J; Schweitzer P
Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
[TBL] [Abstract][Full Text] [Related]
10. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol.
Castellucci A
Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation.
Veloso HH; de Paola AA
J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626
[No Abstract] [Full Text] [Related]
14. [Can atrial fibrillation be managed without anti-arrhythmia drugs?].
Blanc JJ; Mansourati J
Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():63-7. PubMed ID: 7786126
[TBL] [Abstract][Full Text] [Related]
15. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
[TBL] [Abstract][Full Text] [Related]
16. [The interaction of antiarrhythmic drugs with other drugs].
Yamaguchi I
Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571
[No Abstract] [Full Text] [Related]
17. Pharmacologic control of heart rate in atrial fibrillation.
Falk RH
Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
[TBL] [Abstract][Full Text] [Related]
18. [Significance of neurotropic component in therapeutic effect of the anti-arrhythmia agents].
Sheikh-Zade IuR; Cherednik IL; Galenko-Iaroshevskiĭ PA
Biull Eksp Biol Med; 1999 Mar; 127(3):353-6. PubMed ID: 10225121
[No Abstract] [Full Text] [Related]
19. [Drug therapy of atrial fibrillation].
Fazekas T; Csanádi Z; Varró A
Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
[TBL] [Abstract][Full Text] [Related]
20. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
